Literature DB >> 20055663

3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes.

Jun Li1, Ran Tao, Wei Wu, Hongcui Cao, Jiaojiao Xin, Jun Li1, Jing Guo, Longyan Jiang, Changyou Gao, Achilles A Demetriou, Daniel L Farkas, Lanjuan Li.   

Abstract

UNLABELLED: Liver tissue engineering with hepatic stem cells provides a promising alternative to liver transplantation in patients with acute and chronic hepatic failure. In this study, a three-dimensional (3D) bioscaffold was introduced for differentiation of rat bone marrow mesenchymal stem cells (BMSCs) into hepatocytes. For hepatocyte differentiation, third passage BMSCs isolated from normal adult F344 rats were seeded into collagen-coated poly(lactic-co-glycolic acid) (C-PLGA) 3D scaffolds with hepatocyte differentiation medium for 3 weeks. Hepatogenesis in scaffolds was characterized by reverse transcript PCR, western blot, confocal laser scanning microscopy (CLSM), periodic acid-Schiff staining, histochemistry, and biochemical assays with hepatic-specific genes and markers. A monolayer culture system was used as a control differentiation group. The results showed that isolated cells possessed the basic features of BMSCs. Differentiated hepatocyte-like cells in C-PLGA scaffolds expressed hepatocyte-specific markers [eg, albumin (ALB), alpha-fetoprotein, cytokeratin 18, hepatocyte nuclear factor 4alpha, and cytochrome P450] at mRNA and protein levels. Most markers were expressed in C-PLGA group 1 week earlier than in the control group. Results of biocompatibility indicated that the differentiated hepatocyte-like cells grew more stably in C-PLGA scaffolds than that in controls during a 3-week differentiation period. The significantly higher metabolic functions in hepatocyte-like cells in the C-PLGA scaffold group further demonstrated the important role of the scaffold.
CONCLUSION: As the phenomenon of transdifferentiation is uncommon, our successful transdifferentiation rates of BMSCs to mature hepatocytes prove the superiority of the C-PLGA scaffold in providing a suitable environment for such a differentiation. This material can possibly be used as a bioscaffold for liver tissue engineering in future clinical therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20055663     DOI: 10.1089/scd.2009.0415

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  30 in total

Review 1.  Regenerative surgery: tissue engineering in general surgical practice.

Authors:  Victor W Wong; Derrick C Wan; Geoffrey C Gurtner; Michael T Longaker
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

2.  A comparison of the chemical and liver extract-induced hepatic differentiation of adipose derived stem cells.

Authors:  Truong Hai Nhung; Nguyen Hai Nam; Nguyen Thi Kim Nguyen; Huynh Nghia; Nguyen Van Thanh; Phan Kim Ngoc; Phuc Van Pham
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-08-15       Impact factor: 2.416

3.  Biomaterials for liver tissue engineering.

Authors:  Era Jain; Apeksha Damania; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-27       Impact factor: 6.047

4.  3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.

Authors:  Simonas Daunys; Agnė Janonienė; Indrė Januškevičienė; Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size.

Authors:  Qiu Li Loh; Cleo Choong
Journal:  Tissue Eng Part B Rev       Date:  2013-06-25       Impact factor: 6.389

6.  Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function.

Authors:  Aleksander Skardal; Leona Smith; Shantaram Bharadwaj; Anthony Atala; Shay Soker; Yuanyuan Zhang
Journal:  Biomaterials       Date:  2012-04-02       Impact factor: 12.479

7.  Low frequency magnetic force augments hepatic differentiation of mesenchymal stem cells on a biomagnetic nanofibrous scaffold.

Authors:  Dillip Kumar Bishi; Soma Guhathakurta; Jayarama Reddy Venugopal; Kotturathu Mammen Cherian; Seeram Ramakrishna
Journal:  J Mater Sci Mater Med       Date:  2014-07-11       Impact factor: 3.896

8.  Effect of Stem Cell Treatment on Acute Liver Failure Model Using Scaffold.

Authors:  Hyeon Tae Kang; Dae Won Jun; Kiseok Jang; Jeong-Kyu Hoh; Jai Sun Lee; Waqar Khalid Saeed; Yeon Ji Chae; Jin Ho Lee
Journal:  Dig Dis Sci       Date:  2018-11-12       Impact factor: 3.199

9.  Promoting the recovery of injured liver with poly (3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) scaffolds loaded with umbilical cord-derived mesenchymal stem cells.

Authors:  Pengshan Li; Jin Zhang; Jing Liu; Huan Ma; Jie Liu; Puchang Lie; Yuechun Wang; Gexiu Liu; Huilan Zeng; Zhizhong Li; Xing Wei
Journal:  Tissue Eng Part A       Date:  2014-11-14       Impact factor: 3.845

10.  Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine.

Authors:  Zhen Pan; Jiandong Ding
Journal:  Interface Focus       Date:  2012-03-14       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.